2016-11: Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program

Status: Completed
Location: See all (31) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: t
View:

• Subject is male or female, 50 years of age or older.

• Subject meets one of two lung cancer screening criteria below.

‣ Subject is a candidate for LDCT lung cancer screening and is scheduled for a baseline LDCT scan. There may be circumstances when a patient cannot have an LDCT scan (e.g., due to insurance issues). In these cases, it is allowable for a patient to have a CT scan in order to meet the inclusion criteria. OR

⁃ Subject has had previous LDCT scan(s) for lung cancer screening and the most recent LDCT scan prior to enrollment is negative for pulmonary nodules (Lung-RADS category 1, no nodules).

• Subject understands the study procedures and is able to provide informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator.

Locations
United States
Alabama
Achieve Clinical Research
Birmingham
Arkansas
Highlands Oncology Group
Springdale
Arizona
Phoenix Medical Group
Peoria
California
NewportNativeMD, Inc.
Newport Beach
Palmtree Clinical Research, Inc.
Palm Springs
Florida
International Research Partners, LLC
Doral
Clinical Trials of Florida, LLC
Miami
Sarkis Clinical Trials
Ocala
Pasadena Center for Medical Research, Inc.
Saint Petersburg
Sarasota Memorial Hospital
Sarasota
Iowa
UnityPoint Health - St. Luke's Hospital
Cedar Rapids
Massachusetts
Lahey Clinic, Inc.
Burlington
Maryland
Meritus Center for Clinical Research
Hagerstown
Missouri
Boone Hospital Center
Columbia
Nebraska
Creighton University
Omaha
New Jersey
Pulmonary Ultimate Research Experience, LLC
Toms River
New York
Northwell Health Physicians Pulmonary Medicine
Manhasset
Gotham Cardiovascular Research, PC
New York
Ohio
Clinical Trials Developers, Inc.
Milford
Pennsylvania
Chest Diseases of Northwestern PA
Erie
Allegheny Health Network
Pittsburgh
Research Protocol Management Specialists
Pittsburgh
Rhode Island
Safe Harbor Clinical Research
East Providence
South Carolina
Anderson Pharmaceutical Research, LLC
Anderson
Charleston Research Institution
Charleston
Medical University of South Carolina
Charleston
Clinical Research of Charleston
Mount Pleasant
South Carolina Pharmaceutical Research
Spartanburg
Union Pharmaceutical Research
Union
Virginia
Pulmonary Associates of Richmond, Inc.
Richmond
Wisconsin
ProHealth Care
Waukesha
Time Frame
Start Date: 2017-04-06
Completion Date: 2021-01-31
Participants
Target number of participants: 1718
Treatments
Lung Cancer Screening Patients - No Nodules
Subjects in an low dose CT screening program that present no nodules.
Lung Cancer Screening Patients - Nodules
Subjects in an low dose CT screening program that present nodules. Additional follow-up data will be collected for up to 12 months and an additional blood sample collected
Related Therapeutic Areas
Sponsors
Leads: Exact Sciences Corporation

This content was sourced from clinicaltrials.gov

Similar Clinical Trials